Elizabeth Krakow is a Hematology physician affiliated with Fred Hutch Cancer Center. OpenAlex indexes 61 publications with 660 citations (h-index 14); ClinicalTrials.gov lists 4 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Eastlake Ave E
Seattle, WA 981094405
Telephone
206-520-5700Registry record last updated 12 Feb 2016.
Clinical trials
- DR-18 to Prevent or Treat Acute Myeloid Leukemia or Myelodysplastic Syndrome Relapse After Hematopoietic Cell Transplantation, the DR. DREAM Trial
Sponsor: Fred Hutchinson Cancer Center
- Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
Sponsor: Fred Hutchinson Cancer Center
- HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Sponsor: Fred Hutchinson Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Illumina, Inc.Program year20251 payment
- Alexion Pharmaceuticals, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Donor Lymphocyte Infusion in Myeloid Malignancies: Reassessing Predictors of Response
Biology of Blood and Marrow Transplantation
2026 - Late Effects and Quality of Life in Long-Term Survivors Following Hematopoietic Cell Transplantation and Post-Transplantation Cyclophosphamide-Based GvHD Prophylaxis
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Stanley Riddell, MD
Fred Hutch Cancer Center
Sunil Hingorani, MD, PhD
Fred Hutch Cancer Center
Paul Nghiem
Fred Hutch Cancer Center
Soheil Meshinchi, MD, PhD
Fred Hutch Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”